ReviewESMO open2021

Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review.

I Solares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.